Targeting advanced glycation end products: potential therapeutic approaches for mitigating diabetic intervertebral disc degeneration?
Diabetes mellitus is strongly associated with accelerated intervertebral disc degeneration, a condition that significantly contributes to lower back pain and reduced quality of life. Emerging evidence indicates that advanced glycation end products (AGEs) are key mediators in the pathophysiology of d...
Saved in:
| Main Authors: | Luyang Wang, Qipeng Shao, Haiyang Wu, Cheng Li |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2025-07-01
|
| Series: | Frontiers in Endocrinology |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fendo.2025.1618984/full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
A Bibliometric Study of Interleukin Cytokines in the Treatment of Intervertebral Disc Degeneration
by: Wang H, et al.
Published: (2025-07-01) -
The dual effects of iron deficiency on intervertebral disc development and on acute injury-induced disc degeneration
by: Hengrui Chang, et al.
Published: (2025-06-01) -
Immune microenvironment in intervertebral disc degeneration: pathophysiology and therapeutic potential
by: Qian Ren, et al.
Published: (2025-07-01) -
Biomaterial-based circular RNA therapeutic strategy for repairing intervertebral disc degeneration
by: Hongze Chang, et al.
Published: (2025-03-01) -
Assessment of the Concentration of Transforming Growth Factor Beta 1–3 in Degenerated Intervertebral Discs of the Lumbosacral Region of the Spine
by: Rafał Staszkiewicz, et al.
Published: (2024-11-01)